| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |